The authors have developed a new suborbital tear trough-malar extended implant that provides a comprehensive augmentation of the entire suborbital rim and malar region. The results have been excellent in all cases. There have been no postoperative symptoms relating to the infraorbital nerve. The major postoperative sequela is chemosis of a minor or significant degree in most patients. There have been four cases of a slightly retracted eyelid, which have resolved spontaneously in the course of 6 to 8 weeks. This technique does not require any removal of fat from the orbit nor does it require extensive dissection of fat. This operation successfully and satisfactorily creates an optimum blending of the lid–cheek junction.